Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhou, Wencheng ^a   Mo, Xiaoting ^a   Cui, Wenhui ^a,b   Zhang, Zhihui ^a   Li, Delin ^c   Li, Liucheng ^a   Xu, Liang ^a   Yao, Hongwei ^a   Gao, Jian ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BIOLOGICAL MODEL; CELL LINE; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; LUNG ALVEOLUS; LUNG FIBROSIS; METABOLISM; MOUSE; PATHOLOGY; RAT;

ANIMALS; BLEOMYCIN; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; GENE SILENCING; MICE; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RATS; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85006459468     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38646     Document Type: Article

References (33)

1. Wolters, P. J., Collard, H. R., Jones, K. D. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9, 157-179, doi: 10. 1146/annurev-pathol-012513-104706 (2014).
2. Raghu, G., et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med 2, 566-572, doi: 10. 1016/S2213-2600(14)70101-8 (2014).
3. Idiopathic Pulmonary Fibrosis Clinical Research, N., et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366, 1968-1977, doi: 10. 1056/NEJMoa1113354 (2012).
4. Yao, H. W., Li, J. Epigenetic modifications in fibrotic diseases: implications for pathogenesis and pharmacological targets. J Pharmacol Exp Ther 352, 2-13, doi: 10. 1124/jpet. 114. 219816 (2015).
5. Borensztajn, K., Crestani, B., Kolb, M. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers-insights from the bench side. Respiration 86, 441-452, doi: 10. 1159/000357598 (2013).
6. King, T. E. Jr., et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184, 92-99, doi: 10. 1164/rccm. 201011-1874OC (2011).
7. Lamouille, S., Xu, J., Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15, 178-196, doi: 10. 1038/nrm3758 (2014).
8. Nieto, M. A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27, 347-376, doi: 10. 1146/annurev-cellbio-092910-154036 (2011).
9. Muqbil, I., Wu, J., Aboukameel, A., Mohammad, R. M., Azmi, A. S. Snail nuclear transport: the gateways regulating epithelial-tomesenchymal transition Semin Cancer Biol 27, 39-45, doi: 10. 1016/j. semcancer. 2014. 06. 003 (2014).
10. Lu, X., et al. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo. Oncotarget, doi: 10. 18632/oncotarget. 9287 (2016).
11. Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53, 401-426, doi: 10. 1146/annurevpharmtox-011112-140320 (2013).
12. Kay, H. Y., et al. Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCdelta-GSK3beta pathway. Br J Pharmacol 163, 1653-1665, doi: 10. 1111/j. 1476-5381. 2010. 01095. x (2011).
13. Marcotte, D., et al. Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg Med Chem 21, 4011-4019, doi: 10. 1016/j. bmc. 2013. 04. 019 (2013).
14. Lee, J. C., et al. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Br J Pharmacol 171, 237-252, doi: 10. 1111/bph. 12440 (2014).
15. Ryoo, I. G., Shin, D. H., Kang, K. S., Kwak, M. K. Involvement of Nrf2-GSH signaling in TGFbeta1-stimulated epithelial-tomesenchymal transition changes in rat renal tubular cells. Arch Pharm Res 38, 272-281, doi: 10. 1007/s12272-014-0380-y (2015).
16. Mingot, J. M., Vega, S., Maestro, B., Sanz, J. M., Nieto, M. A. Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors. J Cell Sci 122, 1452-1460, doi: 10. 1242/jcs. 041749 (2009).
17. Wuyts, W. A., et al. The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J 41, 1207-1218, doi: 10. 1183/09031936. 00073012 (2013).
18. Kim, K. K., et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103, 13180-13185, doi: 10. 1073/pnas. 0605669103 (2006).
19. Kikuchi, N., et al. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 11, 31, doi: 10. 1186/1465-9921-11-31 (2010).
20. Shin, D.-h., et al. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radical Biology and Medicine 48, 1051-1063, doi: 10. 1016/j. freeradbiomed. 2010. 01. 021 (2010).
21. Zhang, X., et al. Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. Mol Med Rep 12, 1347-1355, doi: 10. 3892/mmr. 2015. 3556 (2015).
22. Wang, Y., et al. Epigallocatechin-3-gallate attenuates transforming growth factor-beta1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Biomed Pharmacother 70, 260-267, doi: 10. 1016/j. biopha. 2015. 01. 032 (2015).
23. Saitoh, M. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-beta signaling during tumor progression. Cancer Sci 106, 481-488, doi: 10. 1111/cas. 12630 (2015).
24. Batlle, E., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84-89, doi: 10. 1038/35000034 (2000).
25. Li, H., et al. XBP1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cells. Cell Signal 27, 82-89, doi: 10. 1016/j. cellsig. 2014. 09. 018 (2015).
26. Yuan, H., et al. ALX1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of ovarian cancer cells. Cancer Res 73, 1581-1590, doi: 10. 1158/0008-5472. CAN-12-2377 (2013).
27. Peinado, H., Quintanilla, M., Cano, A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 278, 21113-21123, doi: 10. 1074/jbc. M211304200 (2003).
28. Mo, X. T., et al. Inositol-requiring protein 1-X-box-binding protein 1 pathway promotes epithelial-mesenchymal transition via mediating snail expression in pulmonary fibrosis. Int J Biochem Cell Biol 65, 230-238, doi: 10. 1016/j. biocel. 2015. 06. 006 (2015).
29. Yao, H., et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest 122, 2032-2045, doi: 10. 1172/JCI60132 (2012).
30. Xu, L., et al. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-beta1-mediated type I collagen abnormal deposition in rats. J Pharm Pharmacol 66, 1786-1795, doi: 10. 1111/jphp. 12308 (2014).
31. Li, L., et al. Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats. Phytomedicine 22, 111-119, doi: 10. 1016/j. phymed. 2014. 10. 011 (2015).
32. Zhao, P., et al. Total Glucosides of Danggui Buxue Tang Attenuate BLM-Induced Pulmonary Fibrosis via Regulating Oxidative Stress by Inhibiting NOX4. Oxid Med Cell Longev 2015, 645814, doi: 10. 1155/2015/645814 (2015).
33. Szapiel, S. V., Elson, N. A., Fulmer, J. D., Hunninghake, G. W., Crystal, R. G. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis 120, 893-899, doi: 10. 1164/arrd. 1979. 120. 4. 893 (1979).